Li H - Search Results

1

Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma.

Wu H, Wang W, Liu F, Weisberg EL, Tian B, Chen Y, Li B, Wang A, Wang B, Zhao Z, McMillin DW, Hu C, Li H, Wang J, Liang Y, Buhrlage SJ, Liang J, Liu J, Yang G, Brown JR, Treon SP, Mitsiades CS, Griffin JD, Liu Q, Gray NS. Wu H, et al. Among authors: li h, li b. ACS Chem Biol. 2014 May 16;9(5):1086-91. doi: 10.1021/cb4008524. Epub 2014 Mar 17. ACS Chem Biol. 2014. PMID: 24556163 Free PMC article.

2

Sodium chloride (NaCl) potentiates digoxin-induced anti-tumor activity in small cell lung cancer.

Deng K, Shen J, Wang W, Li M, Li H, Chen C, Zhao H, Zhang M, Xue T, Liu Q, Lui VWY, Hong B, Lin W. Deng K, et al. Among authors: li h, li m. Cancer Biol Ther. 2019;20(1):52-64. doi: 10.1080/15384047.2018.1504723. Epub 2018 Sep 5. Cancer Biol Ther. 2019. PMID: 30183476 Free PMC article.

3

FK228 sensitizes radioresistant small cell lung cancer cells to radiation.

Li H, Ma L, Bian X, Lv Y, Lin W. Li H, et al. Clin Epigenetics. 2021 Feb 25;13(1):41. doi: 10.1186/s13148-021-01025-5. Clin Epigenetics. 2021. PMID: 33632300 Free PMC article.

4

The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer.

Li H, Wang H, Deng K, Han W, Hong B, Lin W. Li H, et al. Cancer Biomark. 2019;24(1):51-59. doi: 10.3233/CBM-181692. Cancer Biomark. 2019. PMID: 30614795

5

Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer.

Yin YP, Shi WH, Deng K, Liu XL, Li H, Lv XT, Lui VWY, Ding C, Hong B, Lin WC. Yin YP, et al. Among authors: li h. Acta Pharmacol Sin. 2021 Aug;42(8):1298-1310. doi: 10.1038/s41401-020-00544-w. Epub 2020 Nov 2. Acta Pharmacol Sin. 2021. PMID: 33139838 Free PMC article.

6

A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer.

Liu X, Wang W, Yin Y, Li M, Li H, Xiang H, Xu A, Mei X, Hong B, Lin W. Liu X, et al. Among authors: li h, li m. Invest New Drugs. 2019 Dec;37(6):1166-1176. doi: 10.1007/s10637-019-00750-2. Epub 2019 Mar 2. Invest New Drugs. 2019. PMID: 30825105

7

Graphitic Carbon Nitride Quantum Dots Embedded in Carbon Nanosheets for Near-Infrared Imaging-Guided Combined Photo-Chemotherapy.

Liu H, Lv X, Qian J, Li H, Qian Y, Wang X, Meng X, Lin W, Wang H. Liu H, et al. Among authors: li h. ACS Nano. 2020 Oct 27;14(10):13304-13315. doi: 10.1021/acsnano.0c05143. Epub 2020 Oct 5. ACS Nano. 2020. PMID: 33016066

8

Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer.

Li M, Shan W, Hong B, Zou J, Li H, Han D, Zhang Y, Li L, Li D, Lin W. Li M, et al. Among authors: li d, li h, li l. Sci Rep. 2020 Jul 29;10(1):12705. doi: 10.1038/s41598-020-69615-6. Sci Rep. 2020. PMID: 32728103 Free PMC article.

9

Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway.

Li M, Shan W, Hua Y, Chao F, Cui Y, Lv L, Dou X, Bian X, Zou J, Li H, Lin W. Li M, et al. Among authors: li h. Front Cell Dev Biol. 2021 May 31;9:661602. doi: 10.3389/fcell.2021.661602. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34136482 Free PMC article.

10

The distinct clinicopathological and prognostic implications of PIK3CA mutations in breast cancer patients from Central China.

Wu H, Wang W, Du J, Li H, Wang H, Huang L, Xiang H, Xie J, Liu X, Li H, Lin W. Wu H, et al. Among authors: li h. Cancer Manag Res. 2019 Feb 14;11:1473-1492. doi: 10.2147/CMAR.S195351. eCollection 2019. Cancer Manag Res. 2019. PMID: 30863158 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112,430 results

Search Page